Assembly Biosciences, Inc.
ASMB
$26.93
$0.281.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.81% | 62.82% | 2.71% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.81% | 62.82% | 2.71% | -- | -- |
| Cost of Revenue | -0.82% | 25.02% | 29.75% | 24.86% | 29.83% |
| Gross Profit | 15.88% | 10.86% | -80.15% | 38.38% | 38.31% |
| SG&A Expenses | 2.61% | -2.72% | -47.07% | 1.47% | -9.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.08% | 17.23% | -4.18% | 18.29% | 18.57% |
| Operating Income | 9.10% | 7.34% | 8.12% | 27.19% | 30.22% |
| Income Before Tax | 5.10% | 2.85% | 4.74% | 33.34% | 36.40% |
| Income Tax Expenses | -- | -- | -330.30% | -- | -- |
| Earnings from Continuing Operations | 8.55% | 2.85% | 5.72% | 33.34% | 34.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.55% | 2.85% | 5.72% | 33.34% | 34.00% |
| EBIT | 9.10% | 7.34% | 8.12% | 27.19% | 30.22% |
| EBITDA | 9.12% | 7.38% | 7.76% | 26.85% | 29.90% |
| EPS Basic | 32.60% | 29.04% | 23.22% | 54.02% | 49.06% |
| Normalized Basic EPS | 30.05% | 29.04% | 22.42% | 54.02% | 50.92% |
| EPS Diluted | 32.60% | 29.04% | 23.22% | 54.02% | 49.06% |
| Normalized Diluted EPS | 30.05% | 29.04% | 22.42% | 54.02% | 50.92% |
| Average Basic Shares Outstanding | 35.68% | 36.89% | 22.80% | 45.00% | 29.57% |
| Average Diluted Shares Outstanding | 35.68% | 36.89% | 22.80% | 45.00% | 29.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |